10 provincial supplies negotiations: domestic only 6 products won the bid (with list)

According to Cypress Blue equipment combing, the total amount of procurement of 168,987, the proposed selection involves 56 products, of which 6 products for domestic products to be selected, 50 products for imported products to be selected.
6 domestic products, Ebernod (Beijing) Medical Technology Co., Ltd. to choose 3, Wuxi Leiming Vision Kang Technology Co., Ltd. to choose 2, Tianjin Century Kantai Biomedical Engineering Co., Ltd. to choose 1.
band procurement documents show that Ningxia, Gansu, Qinghai, Xinjiang, Xinjiang Construction Corps, Hunan, Guangxi, Guizhou, Hainan and Shaanxi 10 provinces (regions, corps) within the region of the three-level public medical institutions, with artificial crystal-related surgery, such as secondary public medical institutions will participate in this joint belt procurement.
It is understood that artificial lenses for the treatment of cataracts, is the world's largest use of artificial organs and implanted medical device products, and cataracts are the first major category of ophthalmology diseases, at present, through surgical implantation of artificial lenses to replace the turbid natural lens is the only effective means of treating cataracts.
the artificial crystal belongs to Class III medical devices, which are generally divided into two categories: hard artificial crystal and soft artificial crystal.
according to the firestone creation combing, hard artificial crystals are relatively low-end, the price fluctuates in the hundreds of yuan, soft artificial crystals are more high-end, the price fluctuates between 1,000 yuan and 10,000 yuan.
now soft artificial crystals are the main profit point of the market, but also the field of competition between medical device companies.
Xinhua News Agency client news shows that the current artificial crystal product batch number of domestic enterprises have Ebonod, Wuxi Leiming Vision Kang and other 7, with about 20 product registration certificates;
results can also be seen from the proposed selection, occupying the main domestic artificial crystal market is still imported products.
According to Limu information consulting data, from the market competition pattern, in 2018 the United States Erkang, Eye Health and Dr. Lun three companies monopolize more than 80% of the global artificial crystal market share, the domestic market is more obvious, imported brands occupy more than 95% of the domestic soft crystal market share.
with the continuous improvement of domestic technology, Ebernod and Wuxi Leiming Tvkang have been obtained the registration certificate of soft crystals.
The four major foreign enterprises occupy the main market, whether there can be a breakthrough in domestic production from this result, the domestic enterprises Inbnod proposed to select the most products, but if based on sales calculation, its overall market share is still less than 10%.
On July 29th, Ebernod logged on to the board, and prospecto data show that the market share of Ebernod's artificial crystal products sales has increased from about 3% in 2016 to about 10% in 2019, and the market share of sales amount calibre has increased from about 2% in 2016 to about 7% in 2019.
it is understood that Ebernod was founded in 2010, headquartered in Beijing, the main products cover surgery and vision two major areas, of which the core products in the field of surgery for artificial lenses, the core products in the field of vision for corneal plastic mirrors.
and corneal plastic mirror weight is about 0.02g, the optical part diameter of about 6mm, thickness of about 0.2 to 0.8mm, is a relatively small, sophisticated optical medical equipment.
according to the prospectos, Ebernod's operating income is mainly dependent on artificial crystals, with revenues of 69 million yuan, 120 million yuan and 180 million yuan in 2017-2019, accounting for 92.90 percent, 94.36 percent and 91.74 percent of the company's revenue, respectively.
Ai Bonod also said that the domestic artificial crystal market has long been occupied by imported products, although the company's products have achieved partial import substitution, but overall market share is still low.
estimates, in the last two years, Ebernod artificial crystals in the global sales volume caliber market share of about 1%, by sales amount of the market share of about 0.75%.
Currently, the major advanced technologies for artificial crystals are controlled by the four major international ophthalmology medical device companies, including Ercon (United States), Johnson and Johnson (United States), Dr. Len (United States), and ZEISS (Germany), which also account for the majority of the international artificial crystal market.
According to Ercon's reports and estimates, Ercon's market share in the global artificial crystalline market in 2017 was 31%, Johnson and Johnson's 22%, Dr. Len's 6%, ZEISS's 4%, and the four companies together accounted for 63% of the global market share.
the winning price announced this 10 provinces joint belt volume procurement, artificial crystal prices will be how big a decline? Although no price reduction information has been released, several regions have completed the purchase of artificial crystal belt volume before this time.
People's Daily Online reported that on May 9 this year, the 3-6 alliance completed the purchase of artificial crystalline strip volume, compared with the original purchase price of the joint procurement area, the average price of the proposed bid fell by 54.21 percent, the highest decline of 84.73 percent.
according to the People's Daily, in July 2019, Anhui Province completed the first round of volume procurement, the final average price reduction of the total artificial crystal category 20.5%, the average price reduction of the national product category 18.1%, the average price reduction of the import category 20.9%.
September 29, 2019, Jiangsu Province completed the second consumables alliance negotiations, in which the average decline in ophthalmology artificial crystals was 26.89 percent, the largest decline of 38 percent, according to the Nanjing Daily News.
in its prospectos, Ebernod said that in Anhui Province, the winning bid for its A1-UV model artificial lens products (entry price) was 1950 yuan per piece, a decrease of 18.1%.
In the procurement of the 3-6 Beijing-Tianjin-Hebei and Heji Liaomun Jinlu belt, the proposed price of the two models of artificial lens products of Ebernod A1-UV and A2-UV is 1948 yuan/piece and 1400 yuan/piece, respectively;
Artificial crystal product price range Source: Ebernod prospectus For this 10 provinces with volume procurement, Hua Zhao network senior consultant, pharmaceutical procurement platform experts, Seber blue special lecturer Li Zhixuan has been on the Cypress blue device analysis, this time within 5 using on-site bargaining and voting half mechanism, but considering clinical needs, competition slowed down.
More than 6 basic use of similar improved version of the double envelope system, and the use of the final phase-out system, more shortlisted enterprises, and only winning one or two enterprises, price competition is not so fierce, so the purchase document price reduction program is relatively moderate, the final winning manufacturer's price difference may not be too large.
But at the same time, the volume procurement documents also require enterprises to declare the price of the source of the provincial minimum hanging network price, or provincial (alliance) with volume procurement winning price, or Beijing-Tianjin-Hebei and Heji Liaomun Jinlu Alliance winning price.
also requires enterprises to commit to the product after the election to still be linked with the lowest domestic price.
According to the requirements of the volume procurement documents, the same product, such as the national organization of the belt procurement work to form a new low price, in which the selected price after the effective, the purchase has not yet been implemented, according to the national selected price implementation.
In the future in the domestic other provincial (including joint) volume procurement work, if the same product formed by the selected price, lower than the selected price of this alliance procurement, the relevant enterprises should take the initiative to the alliance province-led collection center to submit a written application, the procurement has not yet been implemented, according to the new low-cost implementation.
accessories: